Sutro Biopharma Inc
|Market Cap (Intraday)||845.36M|
|2yr Forward PE||N/A|
Sutro Biopharma Inc Stock, NASDAQ:STRO
Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.